Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cilastatin/therapeutic use"'
Autor:
Raymond Liang, David Todd, Edmond Chiu, Raymond Yung, P. Y. Chau, Wah-Kit Lam, Tai-Kwong Chan
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:1336-1341
One hundred febrile episodes in 89 neutropenic patients after cytotoxic chemotherapy were randomized to be treated with either ceftazidime or imipenem as initial monotherapy. The clinical characteristics of the two groups of patients were comparable.
Autor:
Stéphan Juergen Harbarth, Christophe Jaccard, Bara Ricou, D. Aymon, Nicolas Troillet, Jacques-André Romand, Jacques Bille, Patrick Ambrosetti, Giorgio Zanetti, Daniel Pablo Lew, M. P. Glauser, Olivier Huber, A. Cometta, G. Praz, René Chioléro, R. Schneider
Publikováno v:
Antimicrobial Agents and Chemotherapy, Vol. 42, No 11 (1998) pp. 2966-2972
Nosocomial pneumonia and acute peritonitis may be caused by a wide array of pathogens, and combination therapy is often recommended. We have previously shown that imipenem-cilastatin monotherapy was as efficacious as the combination of imipenem-cilas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::409e650079991a3321d180c52e940800
https://europepmc.org/articles/PMC89196/
https://europepmc.org/articles/PMC89196/
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics, Vol. 23, No 1 (1998) pp. 11-17
OBJECTIVE: To assess the need and possible indications for a fourth-generation cephalosporin (cefepime). METHOD: A cohort study was carried out over a 17-month period in a 1500-bed Swiss university hospital. RESULTS: In 256 (22.6%) of the 1135 patien
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.